MARSHALL WACE, LLP - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 61 filers reported holding SPERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$93,363
+6.0%
64,388
+26.5%
0.00%
Q4 2022$88,087
-76.4%
50,917
-72.7%
0.00%
-100.0%
Q3 2022$374,000
+1285.2%
186,570
+413.0%
0.00%
Q2 2022$27,000
-88.1%
36,369
+39.7%
0.00%
Q1 2022$227,000
+11.3%
26,027
+47.1%
0.00%
-100.0%
Q2 2019$204,000
+161.5%
17,699
+187.9%
0.00%
Q1 2019$78,0006,1480.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders